Exicure, Inc. Common Stock XCUR
Key Stats
- Today's Range
- $1.35 – $1.48
- 50-Day Range
- $1.18 – $3.20
- 52-Week Range
- $1.18 – $9.50
- Volume
- 23K shs
- Average Volume
- 805K shs
- Market Cap
- $7.97 million
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 0.01%
- Days to Cover
- 1.00
About Exicure, Inc. Common Stock
Exicure Inc is a clinical-stage biotechnology company focused on developing treatments for blood-related diseases, with an emphasis on small-molecule therapies that have the potential to benefit a broad range of patients. The company acquired GPCR Therapeutics USA and secured a license for GPC-100 (Burixafor), a clinical-stage small-molecule compound that inhibits the chemokine receptor CXCR4. GPC-100 has demonstrated the ability to effectively mobilize various cell types, including hematopoietic stem cells and lymphocytes, highlighting its broad therapeutic potential across multiple indications.
Related Stocks
Compare head-to-head: XCUR vs LLY·XCUR vs JNJ·XCUR vs ABBV·XCUR vs ABT
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.